asnd
ASND161.520USD
+7.090+4.59%
종가 05/13, 16:00（ET）시세는 15분 지연됩니다
9.85B시가총액
손실P/E TTM
자세한 내용은 Ascendis Pharma A/S 회사
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
회사 정보
회사 코드ASND
회사 이름Ascendis Pharma A/S
상장일Jan 28, 2015
설립일2006
CEOMr. Jan Moller Mikkelsen
직원 수- -
유형Depository Receipt
회계 연도 종료Jan 28
주소Tuborg Boulevard 12
도시HELLERUP
증권 거래소NASDAQ Global Select Consolidated
국가Denmark
우편 번호2900
전화4570222244
웹사이트https://ascendispharma.dk/
회사 코드ASND
상장일Jan 28, 2015
설립일2006
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
Mr. Mads Bodenhoff
Mr. Mads Bodenhoff
Senior Vice President, Head of Finance and Principal Accounting Officer
Senior Vice President, Head of Finance and Principal Accounting Officer
193.00
--
Mr. Donovan (Jay) Wu
Mr. Donovan (Jay) Wu
Executive Vice President, U.S. President
Executive Vice President, U.S. President
--
--
Dr. Aimee Shu,, M.D.
Dr. Aimee Shu,, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Mr. William Carl (Bill) Fairey, Jr.
Mr. William Carl (Bill) Fairey, Jr.
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
수익 분석
통화: EUR업데이트 시간: Sun, Apr 6
통화: EUR업데이트 시간: Sun, Apr 6
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
사업별EUR
이름
수익
비율
Commercial sale of products
55.71M
96.33%
Rendering of services
1.27M
2.20%
License
851.00K
1.47%
Sale of clinical supply
0.00
0.00%
지역별EUR
이름
수익
비율
North America
48.76M
84.31%
Europe
8.15M
14.09%
Asia
924.00K
1.60%
Rest of world
924.00K
1.60%
사업별
지역별
사업별EUR
이름
수익
비율
Commercial sale of products
55.71M
96.33%
Rendering of services
1.27M
2.20%
License
851.00K
1.47%
Sale of clinical supply
0.00
0.00%
주주
업데이트 시간: 23 hours ago
업데이트 시간: 23 hours ago
주주 통계
유형
주주 통계
주주
비율
RA Capital Management, LP
16.75%
Westfield Capital Management Company, L.P.
9.08%
Avoro Capital Advisors LLC
8.45%
Artisan Partners Limited Partnership
7.37%
Janus Henderson Investors
7.26%
Other
51.09%
주주 통계
주주
비율
RA Capital Management, LP
16.75%
Westfield Capital Management Company, L.P.
9.08%
Avoro Capital Advisors LLC
8.45%
Artisan Partners Limited Partnership
7.37%
Janus Henderson Investors
7.26%
Other
51.09%
유형
주주
비율
Investment Advisor/Hedge Fund
42.03%
Investment Advisor
39.18%
Hedge Fund
25.14%
Research Firm
2.57%
Individual Investor
0.78%
Family Office
0.44%
Family Office
0.44%
Family Office
0.44%
Venture Capital
0.39%
기관 주식 보유
업데이트 시간: Mon, Jan 20
업데이트 시간: Mon, Jan 20
보고 기간
기관 수
보유 주식
비율
변동
2025Q1
487
67.20M
111.31%
-2.54M
2024Q4
488
67.37M
111.00%
-7.76M
2024Q3
475
65.25M
107.66%
-6.23M
2024Q2
459
63.44M
108.94%
-9.21M
2024Q1
453
63.54M
109.13%
-8.68M
2023Q4
430
62.90M
109.00%
-9.55M
2023Q3
414
62.85M
109.61%
-11.90M
2023Q2
426
63.03M
109.93%
-13.27M
2023Q1
427
63.10M
110.08%
-9.14M
2022Q4
426
67.66M
118.40%
-4.66M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
RA Capital Management, LP
10.11M
16.66%
+402.32K
+4.14%
Dec 31, 2024
Westfield Capital Management Company, L.P.
5.53M
9.11%
+394.47K
+7.68%
Dec 31, 2024
Avoro Capital Advisors LLC
5.10M
8.41%
+114.17K
+2.29%
Dec 31, 2024
Artisan Partners Limited Partnership
4.45M
7.33%
+39.31K
+0.89%
Dec 31, 2024
Janus Henderson Investors
4.38M
7.22%
+193.69K
+4.63%
Dec 31, 2024
Fidelity Management & Research Company LLC
4.36M
7.18%
-196.51K
-4.32%
Dec 31, 2024
Capital International Investors
2.86M
4.72%
+753.86K
+35.74%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
2.73M
4.49%
+960.50K
+54.42%
Dec 31, 2024
T. Rowe Price Associates, Inc.
2.28M
3.76%
+162.08K
+7.64%
Dec 31, 2024
MFS Investment Management
1.86M
3.07%
-415.00
-0.02%
Dec 31, 2024
더 보기
관련 ETF
업데이트 시간: Tue, May 6
업데이트 시간: Tue, May 6
이름
비율
Harbor Health Care ETF
18.05%
Innovator IBD Breakout Opportunities ETF
3.14%
American Century Focused Dynamic Growth ETF
2.13%
Virtus LifeSci Biotech Products ETF
1.98%
BNY Mellon Innovators ETF
1.84%
Tema Cardiovascular and Metabolic ETF
1.36%
Invesco Nasdaq Biotechnology ETF
0.99%
ProShares Ultra Nasdaq Biotechnology
0.94%
iShares Biotechnology ETF
0.61%
Main Thematic Innovation ETF
0.61%
더 보기
Harbor Health Care ETF
비율18.05%
Innovator IBD Breakout Opportunities ETF
비율3.14%
American Century Focused Dynamic Growth ETF
비율2.13%
Virtus LifeSci Biotech Products ETF
비율1.98%
BNY Mellon Innovators ETF
비율1.84%
Tema Cardiovascular and Metabolic ETF
비율1.36%
Invesco Nasdaq Biotechnology ETF
비율0.99%
ProShares Ultra Nasdaq Biotechnology
비율0.94%
iShares Biotechnology ETF
비율0.61%
Main Thematic Innovation ETF
비율0.61%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음